The performance and imaging characteristics of ultrahigh speed ophthalmic optical coherence tomography (OCT) are investigated. In vivo imaging results are obtained at 850nm and 1050nm using different configurations of spectral and swept source / Fourier domain OCT. A spectral / Fourier domain instrument using a high speed CMOS linescan camera with SLD light source centered at 850nm achieves speeds of˜91,000 axial scans per second with˜3um axial resolution in tissue. A spectral / Fourier domain instrument using an InGaAs linescan camera with SLD light source centered at 1050nm achieves˜47,000 axial scans per second with˜7um resolution in tissue. A swept source instrument using a novel wavelength swept laser light source centered at 1050nm achieves 100,000 axial scans per second. Retinal diseases seen in the clinical setting are imaged using the 91kHz 850nm CMOS camera and 47kHz 1050nm InGaAs camera based instruments to investigate the combined effects of varying speed, axial resolution, center wavelength, and instrument sensitivity on image quality. The novel 1050nm swept source / Fourier domain instrument using a recently developed commercially available short cavity laser source images at 100,000 axial scans per second and is demonstrated in the normal retina. The dense 3D volumetric data sets obtained with ultrahigh speed OCT promise to improve reproducibility of quantitative measurements, enabling early diagnosis as well as more sensitive assessment of disease progression and response to therapy.
INTRODUCTION

Optical Coherence Tomography (OCT)
1 is an imaging technology that allows for non-invasive and in vivo imaging of the human retina. Interferometric detection of backscattered light from the sample achieves micron level resolution imaging with high sensitivity and large dynamic range. Imaging with OCT enables 2D and 3D visualization of the retina, which facilitates the detection and monitoring of retinal pathologies, as well as monitoring of response to therapy. 2 The first implementations of OCT operated with time domain detection, [3] [4] [5] however more recent Fourier domain detection techniques offer a significant speed and sensitivity advantage. Fourier domain OCT imaging can be performed with a spectrometer based 6, 7 or swept laser source based 8, 9 OCT imaging system. Most demonstrations [10] [11] [12] [13] of spectral / Fourier domain OCT imaging in the human eye have imaged at approximately 25,000-29,000 axial scans per second. Swept source ophthalmic imaging has been demonstrated in research systems with axial scan rates in the 10kHz -40kHz range. Examples of such demonstrations include systems with an axial scan rate of 18.8kHz centered at 1050nm, 14 43.2kHz at 855nm,
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43kHz at 840nm, 16 16kHz at 850nm, 17 and 30kHz at 1050nm. 18 Current commercially available ophthalmic OCT imaging systems operate using spectral / Fourier domain detection and image at comparable speeds of 25-50kHz. These speeds are not yet fast enough to obtain dense 3D imaging of the retina due to patient eye movements and blinking, which impose an upper limit on image acquisition times.
Recent advances in high speed linescan camera technology and wavelength swept laser light sources have led to the development of a new class of ultrahigh speed OCT instrumentation that can perform in vivo retinal imaging at speeds˜2-10 times faster than commercially available systems. Ultrahigh speed spectral / Fourier domain OCT retinal imaging of a normal eye has recently been demonstrated at speeds up to 312,500 axial scans per second using a high speed CMOS linescan camera 19 at 800nm wavelengths. Ultrahigh speed swept source / Fourier domain OCT retinal imaging of a normal eye was also recently performed using a Fourier domain model locked (FDML) laser operating at 1050nm with an axial scan rate of 236kHz 20 and at 1060nm with an axial scan rate of 249kHz. 21 Imaging at longer 1050nm wavelengths may offer advantages in terms of increased tissue penetration. 22, 23 However, the relatively narrow width of the water absorption window in the eye at 1050nm limits the maximum bandwidth of the light that can be used. Thus, 850nm imaging is able to achieve finer axial resolutions in tissue. This paper investigates high speed OCT imaging of the human retina in vivo. Representative pathologies are imaged using spectral / Fourier domain OCT with a CMOS linescan camera based instrument operating at 91kHz with light source centered at 850nm and with an InGaAS linescan camera based instrument operating at 47kHz with light source centered at 1050nm. The faster speed of the CMOS linescan camera based instrument enables acquisition of greater lateral sample density 3D volumes when compared to the InGaAs linescan camera based instrument. However, the InGaAs linescan camera based instrument achieves higher sensitivity and improved penetration into retinal tissue. A novel swept source / Fourier domain OCT instrument based on a newly developed commercially available frequency swept laser technology is also presented for the first time. The light source is based on a short cavity laser operating at 100kHz and centered at˜1050nm. This new instrument is evaluated in a normal eye and achieves high sensitivity with long imaging range.
CLINICAL IMAGING WITH SPECTRAL / FOURIER DOMAIN OCT AT 850nm AND 1050nm
OCT imaging was performed on selected patients in the ophthalmology clinic at the New England Eye Center, Tufts Medical Center, Boston, MA using the spectral / Fourier domain OCT imaging systems at 850nm and 1050nm. Using a multiplexed SLD light source (Exalos AG) and high speed CMOS linescan camera (Basler AG), the 850nm system operates at˜91,000 axial scans per second to achieve˜3um axial resolution in tissue with˜92dB sensitivity. A more detailed description of a study using the Basler Sprint linescan camera for ultrahigh speed ophthalmic imaging of normal eyes can be found in a previously published paper. 19 Using a single SLD light source (Superlum) and high speed InGaAs linescan camera (Sensors Unlimited Inc, Goodrich), the 1050nm system operates at˜47,000 axial scans per second to achieve˜7um axial resolution in tissue with 105dB sensitivity (measured in air without equivalent water attenuation of the eye). A more detailed description of this system can be found in a previously published paper.
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The prototype ophthalmic OCT imaging systems were used to acquire images of the macula and optic disc in the human retina. Study protocols were approved by the investigational review boards (IRB) of the Massachusetts Institute of Technology and Tufts Medical Center. Written informed consent was obtained prior to the study. Retinal imaging was performed with an incident average power of 750μW for the 850nm system and 1.8mW for the 1050nm system, consistent with safe retinal exposure as determined by the American National Standards Institute (ANSI) 25 and with exposure levels used in commercial ophthalmic OCT imaging instruments. Imaging was performed using several different scanning and acquisition protocols, as described for each data set below. A1   A3  A4  A5  A6  A7   A8  A9  A10  A11  A12   B1   B3  B4  B5  B6  B7   B8  B9  B10  B11  B12   C1   A2   B2   C2   C3  C4  C5  C6  C7   C8  C9  C10  C11  C12 6mm (400 pixels) 6mm (500 pixels) 6mm (400 pixels) D1  D2  D3  D4  D5  D6   F1  F2  F3  F4  F5  F6 6mm (300 pixels) 6mm (300 pixels) Cirrus (Carl Zeiss Meditec) at˜27,000 axial scans per second with˜5um axial resolution, the data sets acquired by the high speed prototype instrument acquire˜4× the lateral scan data with˜2× the axial resolution. However, sensitivities at the high speeds are lower and imaging through ocular opacities can be challenging, as can be seen by the relatively low dynamic range observed in some of the images. Figure 2 shows images obtained with the 1050nm spectral / Fourier domain OCT imaging system using the high speed InGaAs linescan camera. Images from patient D (Right eye of a 62 year old subject with normal tension glaucoma and optic disc drusen) are shown in Figs. 2(D1-D6) and are extracted from a 2050x21 axial scan volume acquired in 1.4 seconds. Images from patient E (Left eye of a 61 year old subject with wet agerelated macular degeneration) are shown in Figs. 2(E1-E12) and are extracted from a 300x300 axial scan volume acquired in 2.3 seconds. Images from patient F (Right eye of a 77 year old subject with dry age-related macular degeneration) are shown in Figs. 2(F1-F6) and are extracted from a 2050x21 axial scan volume acquired in 1.4 seconds. The higher sensitivity and reduced scattering at the longer 1050nm wavelength of the InGaAs camera based prototype instrument enables deeper penetration into the retina when compared to the 850nm prototype instrument. Imaging through ocular opacities also appears to be improved. However, the axial resolution of the prototype 1050nm instrument is˜2-3× worse than the 850nm instrument, which is able to better resolve the thin fine retinal layers (Figure 1 ).
SWEPT SOURCE / FOURIER DOMAIN OCT IMAGING AT 1050nm
A novel prototype ophthalmic OCT imaging instrument using a recently commercialized swept light source (Axsun Technologies,) at 1050nm was also developed. This light source consists of a MEMS filter, active element, and short cavity. The laser operates at speeds of 100kHz axial scans per second with an approximately 50% duty cycle. The swept source OCT imaging instrument achieves a sensitivity of˜105dB (measured in air without equivalent water attenuation of the eye) with an incident power of 1.8mW.
The prototype instrument was used to acquire in vivo images of the optic disc in the human retina. Retinal imaging was performed with an incident average power of 1.8mW at˜1050nm wavelengths, consistent with safe retinal exposure as determined by the American National Standards Institute (ANSI).
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Figure 3 shows images from a 3D volume consisting of 400x400 axial scans acquired in 1.9 seconds from a normal eye. The OCT fundus image generated from the 3D data set is shown in Fig. 3(G1) and has no noticeable motion in the transverse directions. The cross sectional images shown in Figs. 3(G2) -(G18) exhibit good penetration into the choroid and optic nerve head. However, fixed pattern noise can be observed as horizontal lines spanning the width of the images. This noise may be directly from the swept laser itself since it is observed even when an interferometer is not used. However the source of this noise requires further investigation. Figure 4 (B) shows a composite image consisting of 8 cross sectional images acquired in rapid succession from the same location on the retina that have been registered and averaged. The averaged image shows improved contrast and reduced speckle. Compared to the InGaAs linescan camera based spectral / Fourier domain OCT instrument described in Section 2, the swept source instrument achieves a longer imaging range and reduced sensitivity roll-off at deeper imaging depth.
CONCLUSIONS
We have developed and demonstrated multiple configurations of high speed spectral and swept source / Fourier domain OCT ophthalmic imaging systems at 850nm and 1050nm. One instrument was developed using a high speed CMOS linescan camera. Ultrahigh resolution spectral / Fourier domain OCT imaging at˜3um axial resolution was performed at˜91kHz axial scan rates centered at 850nm wavelength. A second instrument used a high speed InGaAs linescan camera. Spectral / Fourier domain OCT imaging at˜7um axial resolution was performed at˜47kHz axial scan rates at 1050nm wavelength. Imaging of clinical pathologies was performed to G1   G2  G3  G4  G5  G6   G7  G8  G9  G10  G11  G12   G13  G14  G15  G16  G17  G18 6mm (400 pixels) 6mm (400 pixels) 400 x 400 axial scans acquired in 1.9 seconds compare the effects of varying speed, axial resolution, center wavelength, and sensitivity on a representative cross sectional set of patient data with these systems. A novel third instrument images at 100kHz using a recently developed commercially available wavelength swept light source centered at 1050nm and based on short cavity laser technology.
The three high speed systems described in this paper are able to acquire dense 3D volumetric data sets with minimal motion artifacts. Dense volumetric data sets offer continuous retinal coverage which promises to aid in the detection of focal disease and improve the ability to correlate data from visit to visit. Higher instrument sensitivities and deeper imaging into the optic nerve head and choroid are observed with both the spectral and swept source 1050nm systems when compared to the 850nm system. The 1050nm systems also appear to image with higher retinal signal through ocular opacities. However, higher axial resolutions of˜3um are obtained with the 850nm system when compared to the˜7um resolution of the 1050nm systems. The swept source system demonstrates a longer imaging range and superior sensitivity roll-off performance when compared to the spectral systems. However, the swept source system exhibits a fixed pattern and structural noise in the image that is not present in the spectral systems.
The results of this study support the conclusions of previous studies which show that 1050nm wavelengths can achieve increased penetration into the retina. In addition, the superior sensitivity roll off performance observed in swept source OCT extends the imaging range compared to standard and ultrahigh resolution spectral / Fourier domain instruments. Ultrahigh speed imaging can achieve a significant improvement in performance for ophthalmic imaging by obtaining dense 3D data sets of the retina. Imaging at 1050nm wavelengths and/or swept source OCT may lead to the development of practical ultrahigh speed imaging in the clinic where patients often have ocular opacities that reduce signal levels or significant eye motion that hinders data acquisition.
